Building momentum for malaria vaccine research and development: key considerations.

To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and discovery to identify and develop highly effective, long-lasting and affordable next generation malaria vaccines

Mantle heat drives hydrothermal fluids responsible for carbonate-hosted base metal deposits: evidence from 3He/4He of ore fluids in the Irish Pb-Zn ore district

There is little consensus on whether carbonate-hosted base metal deposits, such as the world-class Irish Zn+Pb ore field, formed in collisional or extensional tectonic settings. Helium isotopes have been analysed in ore fluids trapped in sulphides samples from the major base metal deposits of the Irish Zn-Pb ore field in order to quantify the involvement of mantle-derived volatiles, that require melting to be realised, as well as test prevailing models for the genesis of the ore fields. 3He/4He ratios range up to 0.2 Ra, indicating that a small but clear mantle helium contribution is present in the mineralising fluids trapped in galena and marcasite. Sulfides from ore deposits with the highest fluid inclusion temperatures (~200°C) also have the highest 3He/4He (> 0.15 Ra). Similar 3He/4He are recorded in fluids from modern continental regions that are undergoing active extension. By analogy we consider that the hydrothermal fluids responsible for the carbonate-hosted Irish base metal mineralization circulated in thinned continental crust, undergoing extension, and demonstrates that enhanced mantle heat flow is ultimately responsible for driving fluid convection

Progress towards polio eradication in Zimbabwe

No Abstract. Central African Journal of Medicine Vol. 45 (12) 1999: pp. 330-33

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

BACKGROUND: Most health economic evaluations of childhood vaccination only capture the health and short-term economic benefits. Measuring broader, long-term effects of vaccination on productivity and externalities could provide a more complete picture of the value of vaccines. METHOD: MEDLINE, EconLit and NHS-EED databases were searched for articles published between January 1990 and July 2011, which captured broader economic benefits of vaccines in low and middle income countries. Studies were included if they captured at least one of the following categories on broader economic impact: outcome-related productivity gains, behaviour-related productivity gains, ecological externalities, equity gains, financial sustainability gains or macroeconomic benefits. RESULTS: Twenty-six relevant studies were found, including observational studies, economic models and contingent valuation studies. Of the identified broader impacts, outcome-related productivity gains and ecological externalities were most commonly accounted for. No studies captured behaviour-related productivity gains or macroeconomic effects. There was some evidence to show that vaccinated children 8-14 years of age benefit from increased cognitive ability. Productivity loss due to morbidity and mortality was generally measured using the human capital approach. When included, herd immunity effects were functions of coverage rates or based on reduction in disease outcomes. External effects of vaccines were observed in terms of equitable health outcomes and contribution towards synergistic and financially sustainable healthcare programs. CONCLUSION: Despite substantial variation in the methods of measurement and outcomes used, the inclusion of broader economic impact was found to improve the attractiveness of vaccination. Further research is needed on how different tools and techniques can be used in combination to capture the broader impact of vaccination in a way that is consistent with other health economic evaluations. In addition, more country level evidence is needed from low and middle income countries to justify future investments in vaccines and immunization programs. Finally, the proposed broader economic impact framework may contribute towards better communication of the economic arguments surrounding vaccine uptake, leading to investments in immunization by stakeholders outside of the traditional health care sector such as ministries of finance and national treasuries